Metacrine, Inc.
MTCRDelisted Mar 3, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001634379
Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 29
- Q4 2022, +2 vs. previous quarter
- 13F value
- $7.29M
- Reported value at the end of Q4 2022
- Superinvestors holding
- 0
- At the end of Q4 2022
Superinvestors holding MTCR, Q4 2022
No superinvestor reported holding MTCR at the end of Q4 2022.
Latest insider trades
Open-market purchases and sales by Metacrine, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2023 (view filing)4:44 PM ET | Jan 26 | 1 day | York MichaelChief Business Officer | SSale | −107.1K | $0.4141 | −$44.3K | −50.8%103.5K after | |
| Jan 27, 2023 (view filing)4:42 PM ET | Jan 26 | 1 day | Klassen PrestonPresident & CEO | SSale | −380.6K | $0.4132 | −$157.3K | −41.3%541.9K after | |
| Dec 21, 2022 (view filing)5:49 PM ET | Dec 19-21 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +271.6K | $0.3961 | +$107.6K | +4.6%6.16M after | 3 lots |
| Nov 9, 2022 (view filing)6:29 PM ET | Nov 7-9 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +164.3K | $0.4144 | +$68.1K | +2.9%5.89M after | 3 lots |
| Oct 31, 2022 (view filing)1:47 PM ET | Oct 27-28 | 4 days | Leonard Braden Michael10% Owner | PPurchase | +812.5K | $0.3905 | +$317.3K | +16.5%5.72M after | 2 lots |
| Oct 26, 2022 (view filing)4:45 PM ET | Oct 24-26 | 2 days | Leonard Braden Michael10% Owner | PPurchase | +1.26M | $0.3511 | +$443.1K | +34.6%4.91M after | 3 lots |
| Apr 20, 2022 (view filing) | Apr 19 | 1 day | Klassen PrestonPresident & CEO | SSale | −44.7K | $0.5003 | −$22.4K | −4.6%922.5K after | 2 lots |
| Dec 27, 2021 (view filing)4:41 PM ET | Dec 10-22 | 17 daysLate | Behbahani Ali10% Owner | SSale | −497.3K | $0.9944 | −$494.5K | −16.2%2.56M after | 3 lotsDuplicate filing |
| Dec 27, 2021 (view filing)4:40 PM ET | Dec 10-22 | 17 daysLate | New Enterprise Associates 16, L.P. and 2 others10% Owner | SSale | −497.3K | $0.9944 | −$494.5K | −16.2%2.56M after | 3 lots |
| Dec 27, 2021 (view filing) | Dec 10-22 | 17 daysLate | Walker Paul Edward10% Owner | SSale | −497.3K | $0.9932 | −$493.9K | −16.2%2.56M after | 3 lotsDuplicate filing |
Top 10 13F holders, Q4 2022
The largest institutional positions in Metacrine, Inc. at the end of Q4 2022; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 6,167,458 | $2.76M | 2.64% | +6,167,458 | New |
| Tang Capital Management LLC | 4,250,000 | $1.90M | 0.28% | +2,531,780+147.3% | Added |
| ARCH Venture Management, LLC | 2,940,503 | $1.32M | 0.34% | 00.0% | Unchanged |
| Artal Group S.A. | 924,898 | $414.0K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 574,636 | $257.0K | 0.00% | −4,900−0.8% | Reduced |
| Tudor Investment Corp Et Al | 310,027 | $139.0K | 0.00% | −39,073−11.2% | Reduced |
| Vanguard Group Inc | 254,492 | $114.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 204,023 | $91.4K | 0.00% | −1,593−0.8% | Reduced |
| BlackRock Inc. | 100,444 | $45.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 97,033 | $43.0K | 0.00% | +97,033 | New |